Annual Interest Expense
$25.33 M
-$3.58 M-12.37%
31 December 2023
Summary:
Nektar Therapeutics annual interest expense is currently $25.33 million, with the most recent change of -$3.58 million (-12.37%) on 31 December 2023. During the last 3 years, it has fallen by -$11.78 million (-31.75%). NKTR annual interest expense is now -46.45% below its all-time high of $47.31 million, reached on 31 December 2021.NKTR Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$6.02 M
-$388.00 K-6.05%
30 September 2024
Summary:
Nektar Therapeutics quarterly interest expense is currently $6.02 million, with the most recent change of -$388.00 thousand (-6.05%) on 30 September 2024. Over the past year, it has increased by +$110.00 thousand (+1.86%). NKTR quarterly interest expense is now -54.72% below its all-time high of $13.30 million, reached on 31 March 2021.NKTR Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$24.83 M
+$110.00 K+0.45%
30 September 2024
Summary:
Nektar Therapeutics TTM interest expense is currently $24.83 million, with the most recent change of +$110.00 thousand (+0.45%) on 30 September 2024. Over the past year, it has dropped by -$842.00 thousand (-3.28%). NKTR TTM interest expense is now -48.53% below its all-time high of $48.23 million, reached on 31 March 2020.NKTR TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.4% | +1.9% | -3.3% |
| 3 y3 years | -31.8% | -53.0% | -47.6% |
| 5 y5 years | -40.8% | -46.4% | -45.5% |
NKTR Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -46.5% | at low | -53.0% | +8.8% | -47.6% | +1.5% |
| 5 y | 5 years | -46.5% | at low | -54.7% | +8.8% | -48.5% | +1.5% |
| alltime | all time | -46.5% | +147.8% | -54.7% | +142.0% | -48.5% | +644.0% |
Nektar Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.02 M(-6.1%) | $24.83 M(+0.4%) |
| June 2024 | - | $6.41 M(+15.9%) | $24.72 M(+1.0%) |
| Mar 2024 | - | $5.53 M(-19.5%) | $24.46 M(-3.4%) |
| Dec 2023 | $25.33 M(-12.4%) | $6.87 M(+16.2%) | $25.33 M(-1.3%) |
| Sept 2023 | - | $5.91 M(-3.9%) | $25.67 M(-3.9%) |
| June 2023 | - | $6.15 M(-4.0%) | $26.71 M(-3.9%) |
| Mar 2023 | - | $6.41 M(-11.1%) | $27.79 M(-3.9%) |
| Dec 2022 | $28.91 M(-38.9%) | $7.20 M(+3.6%) | $28.91 M(-3.1%) |
| Sept 2022 | - | $6.95 M(-3.8%) | $29.84 M(-16.4%) |
| June 2022 | - | $7.23 M(-4.0%) | $35.69 M(-14.1%) |
| Mar 2022 | - | $7.53 M(-7.4%) | $41.55 M(-12.2%) |
| Dec 2021 | $47.31 M(+27.5%) | $8.13 M(-36.5%) | $47.31 M(-0.1%) |
| Sept 2021 | - | $12.80 M(-2.2%) | $47.37 M(+10.2%) |
| June 2021 | - | $13.09 M(-1.6%) | $42.99 M(+15.4%) |
| Mar 2021 | - | $13.30 M(+62.5%) | $37.24 M(+0.3%) |
| Dec 2020 | $37.12 M(-19.9%) | $8.18 M(-2.9%) | $37.12 M(-10.7%) |
| Sept 2020 | - | $8.43 M(+14.8%) | $41.55 M(-6.3%) |
| June 2020 | - | $7.34 M(-44.3%) | $44.37 M(-8.0%) |
| Mar 2020 | - | $13.17 M(+4.4%) | $48.23 M(+4.1%) |
| Dec 2019 | $46.35 M(+8.4%) | $12.62 M(+12.3%) | $46.35 M(+1.8%) |
| Sept 2019 | - | $11.24 M(+0.3%) | $45.54 M(+2.2%) |
| June 2019 | - | $11.21 M(-0.8%) | $44.56 M(+1.9%) |
| Mar 2019 | - | $11.29 M(-4.3%) | $43.71 M(+2.2%) |
| Dec 2018 | $42.78 M(+4.5%) | $11.80 M(+15.1%) | $42.78 M(+2.0%) |
| Sept 2018 | - | $10.26 M(-1.0%) | $41.94 M(+0.6%) |
| June 2018 | - | $10.36 M(+0.0%) | $41.70 M(+0.8%) |
| Mar 2018 | - | $10.36 M(-5.5%) | $41.36 M(+1.0%) |
| Dec 2017 | $40.95 M(-2.9%) | $10.97 M(+9.5%) | $40.95 M(+1.6%) |
| Sept 2017 | - | $10.01 M(-0.1%) | $40.32 M(-1.2%) |
| June 2017 | - | $10.02 M(+0.7%) | $40.83 M(-1.4%) |
| Mar 2017 | - | $9.95 M(-3.7%) | $41.41 M(-1.8%) |
| Dec 2016 | $42.18 M | $10.33 M(-1.7%) | $42.18 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $10.52 M(-0.9%) | $42.83 M(+2.6%) |
| June 2016 | - | $10.61 M(-1.1%) | $41.74 M(+3.3%) |
| Mar 2016 | - | $10.72 M(-2.4%) | $40.40 M(+3.9%) |
| Dec 2015 | $38.90 M(+0.4%) | $10.98 M(+16.5%) | $38.90 M(+3.6%) |
| Sept 2015 | - | $9.43 M(+1.7%) | $37.54 M(-0.4%) |
| June 2015 | - | $9.27 M(+0.5%) | $37.70 M(-0.9%) |
| Mar 2015 | - | $9.22 M(-4.1%) | $38.06 M(-1.8%) |
| Dec 2014 | $38.76 M(-4.9%) | $9.62 M(+0.3%) | $38.76 M(-1.5%) |
| Sept 2014 | - | $9.59 M(-0.3%) | $39.37 M(-1.5%) |
| June 2014 | - | $9.62 M(-3.0%) | $39.98 M(-1.3%) |
| Mar 2014 | - | $9.92 M(-3.0%) | $40.49 M(-0.7%) |
| Dec 2013 | $40.76 M(+21.5%) | $10.23 M(+0.3%) | $40.76 M(+0.3%) |
| Sept 2013 | - | $10.20 M(+0.6%) | $40.63 M(-2.4%) |
| June 2013 | - | $10.14 M(-0.5%) | $41.61 M(+5.6%) |
| Mar 2013 | - | $10.19 M(+0.9%) | $39.40 M(+17.5%) |
| Dec 2012 | $33.55 M(+228.1%) | $10.10 M(-9.7%) | $33.55 M(+29.2%) |
| Sept 2012 | - | $11.18 M(+41.0%) | $25.97 M(+49.9%) |
| June 2012 | - | $7.93 M(+83.0%) | $17.33 M(+44.8%) |
| Mar 2012 | - | $4.33 M(+71.6%) | $11.97 M(+17.1%) |
| Dec 2011 | $10.22 M(-8.5%) | $2.52 M(-0.7%) | $10.22 M(+0.4%) |
| Sept 2011 | - | $2.54 M(-1.1%) | $10.19 M(-2.7%) |
| June 2011 | - | $2.57 M(-0.6%) | $10.47 M(-3.1%) |
| Mar 2011 | - | $2.58 M(+3.9%) | $10.81 M(-3.3%) |
| Dec 2010 | $11.17 M(-8.2%) | $2.49 M(-12.0%) | $11.17 M(-4.1%) |
| Sept 2010 | - | $2.83 M(-2.9%) | $11.65 M(-0.9%) |
| June 2010 | - | $2.91 M(-1.4%) | $11.75 M(-0.3%) |
| Mar 2010 | - | $2.95 M(-0.4%) | $11.79 M(-3.2%) |
| Dec 2009 | $12.18 M(-19.9%) | $2.96 M(+1.2%) | $12.18 M(+32.2%) |
| Sept 2009 | - | $2.93 M(-0.7%) | $9.21 M(+46.6%) |
| June 2009 | - | $2.95 M(-11.7%) | $6.29 M(+88.3%) |
| Mar 2009 | - | $3.34 M | $3.34 M |
| Dec 2008 | $15.19 M | - | - |
FAQ
- What is Nektar Therapeutics annual interest expense?
- What is the all time high annual interest expense for Nektar Therapeutics?
- What is Nektar Therapeutics annual interest expense year-on-year change?
- What is Nektar Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly interest expense year-on-year change?
- What is Nektar Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Nektar Therapeutics?
- What is Nektar Therapeutics TTM interest expense year-on-year change?
What is Nektar Therapeutics annual interest expense?
The current annual interest expense of NKTR is $25.33 M
What is the all time high annual interest expense for Nektar Therapeutics?
Nektar Therapeutics all-time high annual interest expense is $47.31 M
What is Nektar Therapeutics annual interest expense year-on-year change?
Over the past year, NKTR annual interest expense has changed by -$3.58 M (-12.37%)
What is Nektar Therapeutics quarterly interest expense?
The current quarterly interest expense of NKTR is $6.02 M
What is the all time high quarterly interest expense for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly interest expense is $13.30 M
What is Nektar Therapeutics quarterly interest expense year-on-year change?
Over the past year, NKTR quarterly interest expense has changed by +$110.00 K (+1.86%)
What is Nektar Therapeutics TTM interest expense?
The current TTM interest expense of NKTR is $24.83 M
What is the all time high TTM interest expense for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM interest expense is $48.23 M
What is Nektar Therapeutics TTM interest expense year-on-year change?
Over the past year, NKTR TTM interest expense has changed by -$842.00 K (-3.28%)